文献速递胸部CT

基于秩次的影像组学特征在多队列研究中用于肺腺癌个体化预后评估

Identification of a rank-based radiomic signature with individualized prognostic value for lung adenocarcinoma in a multi-cohort study.
PubMed 文献 · Eur J Radiol · 2024-10-17

本研究利用三个公开多中心队列的234例I-IIIA期肺腺癌患者CT影像,提出基于特征对相对秩次模式的影像组学特征以规避多中心效应。由12个特征对构成的秩次特征在新临床队列162例中验证,预后性能有效(log-rank P=0.0051,C-index=0.73),而其他特征跨中心失去预后能力。

要点

  • 基于12个特征对相对秩次模式的影像组学特征可在个体水平判断死亡风险。
  • 该秩次特征在新临床队列验证有效(log-rank P=0.0051,C-index=0.73)。
  • 其他影像组学特征跨中心失去预后能力,而秩次特征保持稳定。

核心结论

  • 多中心研究显示基于秩次的影像组学特征对肺腺癌预后评估具有准确性和稳定性,并体现临床个体化应用的独特优势。

研究设计与样本

  • 利用三个公开多中心队列234例I-IIIA期肺腺癌患者的CT影像开发特征,另收集162例肺腺癌新临床队列进行独立验证。

诊断标准与关键数值

  • 秩次影像组学特征由12个特征对构成,根据患者CT影像中12个特征对的秩次模式判定个体死亡风险。
  • 在新临床队列中验证预后性能:log-rank P=0.0051,C-index=0.73。
  • 其他影像组学特征跨中心失去预后能力。

临床应用与阅片要点

  • 作者认为基于秩次的影像组学特征在肺腺癌预后评估中具有准确性和稳定性,并体现临床个体化应用的独特优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Radiomics provides an opportunity to evaluate cancer prognosis noninvasively. However, the susceptibility of the radiomic quantitative features to multicenter effects, leads to the clinical dilemma of the radiomic signatures. This study aimed to develop a radiomic signature to circumvent multicenter effects, achieving the individualized prognostic assessment of lung adenocarcinoma (LUAD).

METHODS: Using computed tomography (CT) imaging of 234 stage I-IIIA LUAD patients derived from three public multicenter cohorts, we proposed a rank-based method that utilized the relative rank patterns of quantitative values between radiomic feature pairs within individual patients and established a feature pair signature for LUAD prognosis. We collected a new clinical cohort with 162 LUAD patients for independent validation.

RESULTS: A rank-based radiomic signature, consisting of 12 feature pairs, was developed, and it could determine the mortality risk for an individual according to the rank patterns of 12 feature pairs within the patient's CT imaging. The prognostic performance of the rank-based signature was effectively validated in the new clinical cohort (log-rank P = 0.0051, C-index = 0.73), whereas other signatures lost their prognostic ability across centers. The novel proposed radiomic nomogram significantly improved the prognostic performance of clinicopathological factors. The further radiogenomic analyses revealed the underlying biological characteristics (e.g., Stemness, Ferroptosis, 'ECM') reflected by the rank-based radiomic signature.

CONCLUSIONS: This multicenter study illustrates the accuracy and stability of the rank-based radiomic signature for LUAD prognosis, and demonstrates a unique advantage of clinical individualized application. The biological characteristics underlying the rank-based radiomic signature would accelerate its clinical application.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Wang Z, Yang L, et al. Identification of a rank-based radiomic signature with individualized prognostic value for lung adenocarcinoma in a multi-cohort study. Eur J Radiol. 2024. PMID: 39427495. doi:10.1016/j.ejrad.2024.111782

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。